Details

Likes
0
Followers
0
Directory
Cancer

Expertise

biomedicine cancer biology EUTROC ovarian cancer ovarian cancer biomarkers




Sponsored

Jaume Reventos

Director, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Spain

  • Institut d’Investigació Biomèdica de Bellvitge, Hospital Duran i Reynals, Av Gran Via de l’Hospitalet 199 – 203, 08907 l’Hospitalet de Llobregat, Barcelona,Spain


Biography

Dr Jaume Reventós is the director of the Bellvitge Biomedical Research Institute (Idibell) of the University of Barcelona.

He is the co-founder of Transbiomed and was previously head of the Research Unit in Biomedicine and Translational Oncology at the Vall d’Hebron Research Institute (VHIR).

Reventós founded the VHIR spin-off Transbiomed in 2007 alongside Andreas Doll, Miguel Abal and Raimon Forés. In 2013, the company developed a test for early diagnosis of prostate cancer and began research into biomarkers for ovarian cancer.

Education & Experience


Education



Experience



Location

  • Institut d’Investigació Biomèdica de Bellvitge, Hospital Duran i Reynals, Av Gran Via de l’Hospitalet 199 – 203, 08907 l’Hospitalet de Llobregat, Barcelona,Spain